PROSPECTS AND OPPORTUNITIES
Value sales set to slow down as category matures, with adult combination products and acetaminophen set to remain popular
Value sales of analgesics are expected to slow down over the forecast period, as the category continues to mature. Adult combination products — analgesics is set to see slightly stronger growth, as consumers increasingly focus on products which are able to more effectively improve pain relief by targeting multiple pathways.
Cannaboid-based analgesics set to increase in penetration over the forecast period
Over the forecast period there will be an increased penetration of cannabinoid-based analgesics. CBD and THC derivatives will continue to gain traction as alternatives for chronic pain, neuropathy, and inflammatory conditions.
New legislative changes set to provide tighter restrictions
The new legislative changes in Slovenia and EU are set to provide tighter restrictions in Controls on Opioid-Based Analgesics due to rising concerns over opioid addiction, overdoses, and public health costs. Even low-dose codeine-containing OTC drugs will increasingly be under scrutiny.
Delivery:
Files are delivered directly into your account soon after payment is received and any tax is certification is verified (where applicable).
This report comes in PDF with additional info in Excel included.
Overview:
Understand the latest market trends and future growth opportunities for the Analgesics industry in Slovenia with research from Euromonitor International's team of in-country analysts – experts by industry and geographic specialisation.
Key trends are clearly and succinctly summarised alongside the most current research data available. Understand and assess competitive threats and plan corporate strategy with our qualitative analysis, insight and confident growth projections.
If you're in the Analgesics industry in Slovenia, our research will help you to make informed, intelligent decisions; to recognise and profit from opportunity, or to offer resilience amidst market uncertainty.
The Analgesics in Slovenia report includes:
- Analysis of key supply-side and demand trends
- Detailed segmentation of international and local products
- Historic volume and value sizes, company and brand market shares
- Five year forecasts of market trends and market growth
- Robust and transparent research methodology, conducted in-country
This report answers:
- What is the market size of Analgesics in Slovenia?
- Which are the leading brands in Analgesics in Slovenia?
- How are products distributed in Analgesics in Slovenia?
- How has the regulatory and operating environment for Analgesics changed in Slovenia?
- How are considerations such as stress, self-medication and shifting consumer lifestyles shaping demand for Analgesics
- How significant are wider health concerns and consumer awareness in determining sales?
- Where is future growth expected to be most dynamic?
Analgesics in Slovenia - Category analysis
KEY DATA FINDINGS
Sales of analgesics supported by consumer demand for OTC medicines and natural remedies, and an ageing population
GSK maintains lead thanks to the strength of its Lekadol brand
Pharmacies remain key as trusted sales channels
Value sales set to slow down as category matures, with adult combination products and acetaminophen set to remain popular
Cannaboid-based analgesics set to increase in penetration over the forecast period
New legislative changes set to provide tighter restrictions
Consumer Health in Slovenia - Industry Overview
Consumer Health in 2025: The big picture
Key trends in 2025
Competitive landscape
Channel developments
What next for consumer health?
OTC registration and classification
Vitamins and dietary supplements registration and classification
Self-medication/self-care and preventive medicine
Switches
DISCLAIMER
DEFINITIONS
The following categories and subcategories are included:
Analgesics
-
-
- Adult Acetaminophen
- Adult Aspirin
- Adult Combination Products - Analgesics
- Adult Diclofenac
- Adult Dipyrone
- Adult Ibuprofen
- Adult Ketoprofen
- Adult Naproxen
- Adult OTC Triptans
-
- Paediatric Acetaminophen
- Paediatric Aspirin
- Paediatric Combination Products - Analgesics
- Paediatric Dipyrone
- Paediatric Ibuprofen
- Paediatric Naproxen
-
- Acetaminophen
- Aspirin
- Combination Products - Analgesics
- Diclofenac
- Dipyrone
- Ibuprofen
- Ketoprofen
- Naproxen
- OTC Triptans
-
- Topical Analgesics/Anaesthetic
Analgesics
Analgesics cover systemic and topical pain relievers. Products which include a pain-relief ingredient in addition to another core function are excluded (e.g. a sore throat remedy which includes paracetamol is excluded from the analgesics and instead is included in pharyngeal remedies).
See all of our definitionsWhy buy this report?
- Gain competitive intelligence about market leaders
- Track key industry trends, opportunities and threats
- Inform your marketing, brand, strategy and market development, sales and supply functions
This report originates from Passport, our Analgesics research and analysis database.
NEW REPORT GUARANTEE
If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extraction Free!